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Both petnphigus vulgaris antigen (PVA; Dsg3) and 
petnphigus foliaceus antigen (PFA; Dsgl) are tnem-
bers of the destnoglein subfamily of the cadherin 
supergene fatnily. Another destnosotnal cadherin, 
destnocollin, is occasionally recognized by certain 
petnphigus sera. We present a 38-year-old Japanese 
tnale who showed clinically and histopathologically 
typical features of petnphigus vulgaris, whose sera 
reacted with all PVA, PFA, and destnocollins using 
itntnunoblotting of both hutnan epidertnis and bo-
vine snout epidertnis. Studies using dotnain-specific 
fusion proteins of PFA and PVA suggested that this 
patient's serutn reacted with the intracellular dOlnain 
P emphigus is divided into two major subtypes: pemphi-gus vulgaris (PV) and pemphigus folia ceus (PF) [1]. Brazilj an PF is considered to be an endemic form of PF seen in certain areas in South America [2] . In addition, paraneoplastic pe mphigus [3] and IgA pemphigus/ in-
tercellular IgA ves icul opustular dermatos is [4] have been p roposed 
as new disease entities of the pemphjgus group. The antigens in the 
patients' se ra with which anti-keratinocyte cell-surface autoanti-
bodies react have been investigated extensively. Using both immu-
noprecipitation [5-8] and immunoblotting [9], most PV sera de-
tected the t30-kD PV antigen (PVA). With immunoprecipitation, 
most PF sera de tected the 160-kD PF antigen (PFA) [7,8] , which 
was later identified as desmoglein 1, a major desmosoma l trans-
membrane protein [10]. In contrast, with immunoblotting using 
normal human epidermal extracts, on ly one thil·d of PF sera detect 
PFA [6 ,9], probably because of the presence of conforl11ation-
dependent epitopes that are destroyed during the immul1oblot 
procedure. We and other investigators showed that desmosome 
preparations £i'om bovine l11uzzle epidermis are also useful for 
detecting PFA by immunobJotting [9,11]. With both immul1opre-
cipitation [7 ,8] and iml11unoblotting of bovine desmosome prepa-
rations [9], about half of PV sera recognjze PYA and PFA simu l-
taneously. Moreover, we have recently reported that another 
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of PFA and the extracellular dotnain of PVA, the 
latter of which seetns to be responsible for initiating 
the skin lesion. The patient's serum showed reactivity 
with hutnan destnocollin and was shown to react with 
bovine Dsc2 fusion protein, further suggesting the 
significance of anti-destnocollin autoantibodies in 
petnphigus. These results indicate that certain petn-
phigus cases tnay produce antibodies against tnulti-
pIe antigen tnolecules, although the cotnplex tnech-
anistn of the production of autoantibodies retnains to 
be elucidated. Key /VOI'ds: cadllerill/desmogldll/pemplliglls 
foliacells. ] I"vest Del'matol 104:541-544, 1995 
desmosomal membrane protein , desmocollin , is also recognized by 
certain pemphigus sera [4,12] in immunoblotting of bovine desmo-
some preparations. However, the significance of the anti-desmo-
collin autoantibodies is not yet clear, particularly because there 
have been no pemphjgus cases reported showing reactivity with 
human desi1lOcollin [4,12]. 
R ecent molecular cloning studies have shown that all PFA, PYA, 
and desmocollins belong to the cadhe rin sup ergene tamily [13-16]. 
According to a new nomenclature proposed recently by Buxton et 
al [17], desmosomal cadhel'ins are divided into t""o g roups, desmo-
glein (Dsg) and desmocollin (Dsc), both of which consist of 
multiple isoforms, i. e ., Dsgl-3 and Dsc1-3. Each desl11 ocollin 
isoform consists of the larger "a" fon~; and the smaller "b" form by 
alternative splicing of its mRNA [16.17]. PFA is Dsg1 and PYA is 
Dsg3 [1 7]. 
In this report, we present a clinically and hjstopathologically 
typical case of PV in which the patient's sera detected, in addition 
to PYA, both PFA and desmocollins using immunoblot analyses of 
both normal hUl11a.n epidermal extracts and bovine desmosome 
preparations. Studies using domain-specific fusiOl'] proteins of both 
bovine PFA and human PYA indicated that this patient' s serum 
reacted with the extraceUul ar domain of PYA and with the 
intracellular domain of PFA. Furthermore, th.is patient's serlll11 was 
revealed to react specificalJy with bovine Dsc2 fusion protei.n. 
However, the significance of anti-desmocoUin antibodies in the 
pathogenesis of pemph.igus remains to be elucidated in future 
studies. 
MATERlALS AND METHODS 
Prcscntation of a Case A 38-ycar-old Japanese man prescnted with a 
3-year history of flaccid bullae and erosions predominantly on the trunk , 
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extremi ties. and o ral mucosa. Histo pa tho logy exhibi ted supra basilar acan-
tho lytic b listers in the epidennis. Direct immunoAuo rescence showed IgG 
and C3 deposition at the cell surface in the cpidermis. and indirect 
imm uno Auorescence of no rmal human skin sections revea led anti-cell-
surface antibodies at a titer of 1 :2560. From these results, PV w as diagnosed, 
and the condition was we ll con tro ll ed by combination therapy with oral 
predrusolone and cyclospo rin A. 
Sera We obtained sera fro m tlus paticnt, as well as fro m six PV patients , 
six PF patien ts . and six nonnal vo lun teers as controls. Anti-desmogle in 
monoclonal antibody 32-2B [1 8] and anti-desmocollin monoclonal anti-
body 52-3D [16] were also used . All the pcm plugus sera contained 
circulating an ti-cell-surface an tibodies at a ti ter of greate r than 1 :640, as 
detenruned by indi rect immuno Auorescence of both normal human skin and 
bovine 111uzzlc secti o ns. 
Immunoblot Analysis o f Normal Human Epidermal Extracts and 
Bov ine D csmoso lu c Prep arations l?rc paration of extracts of n a nnal 
human epidermis separated with dispase trea tment, parti al purification of 
desmosom e [rom bovine snout epidermis, and the immunoblot procedure 
were described previously [9] . 
P rep aration of Doma in-Specific F u sion Proteins of Human PVA 
Fusion prote ins for extracellular ECl -2 and EC3-5 domains of human PYA 
with cro-/3-galactosidase were ob ta ined by the same method using pU EX l 
expression plasmid vector (Amcrsham Corp ., Arlington Heights. IL) , as 
described previously [1 5] . In addition, we obtained a fusion protein fo r the 
intracellular domain of human PYA by a similar method . BrieAy, a cDNA 
insert representing the entire intrace llular domain was excised from the 
full - length fo rm of human PY A cDN A by polymerase chain reactio ll 
am plification using primers containing the appro priate restri ction sites and 
subcloned in to the pUEX1 expression plasmid vecto r. 
Product ion of Domain-Spe cific F u sion Proteins of Bovine P FA 
Domain-specific fusion proteins corresponding to the extracellular ECl -5 
domain and the in tracellular domain of bovine pFA were produced as 
reported prev io usly [ 19] USiJlg pDGK5(B), bovine Dsg1 cDNA (a genero us 
gift fro m Dr. Peter J. Koch and Dr. W erner W . Franke, Division of Cell 
Biology, German Cancer R esearch Center. Heidelberg, Germany) [13], and 
pGEX-2T expression vector (Pharmacia, Uppsala. Sweden). 
Production o f F ull- L e ngth F u sion P r ote ins of Bovine Dsclb, 
Dsc2b , and D sc 3b We also o btained full- length fu sion proteins of 
bovine Dsc1 b, Dsc2b , and Dsc3b . To obta in D sc1 b fusion prote in , ti,e 
Xbal-digcsted 2.77-kilobase pair cDNA rragment o b ta ined f rom the bovine 
cDN A clone C N 35 [1 2.16] was blun t-ended by D N A po lymerase (Klenow 
fragment) and subcloned in to Sma I-digested pGEX-3X expression vec to r. 
To obtain Dsc2b fusion protein, the cDN A clone UMDCT2-DC4.1 (a 
generous gift fro m Dr. Peter J. Koch and D r. Werner W. Franke) [20] w as 
first digested with Sad, b lun t-c nded by Klcnow fragment, and then 
digested with X hol. T hc resu ltan t 3.0-kilo base pa ir fragment was subcloned 
in to Smal /Xho l-digested pGEX-4T-3 expression vec to r . Dsc3b fu sion 
protein was obta ined as described previo usly [21] .t Bri eAy, cD N A fi·ag-
ments encoding partia l sequences of bovine Dsc3 were o b ta ined using 
random ly primed cDNA synthesized rrom 1 J-Lg tota l RNA o bta ined fro m 
bovine nasa l epidenllis and Dsc3-specific pri mers. Primers YS8 and Y A2 
incorporated the BamHl restriction site at the 5' end . After we j o ined the 
fragments together, the res ul ta n t construct was subcloned in to pGEX-2T at 
the BamH I site. Fusion proteins with glu tathione-S-transfe rase were ob-
tained as described previo usly [19] . Immunoblotting was perfo rmed as 
mcntioned previously [1 9]. except that :oIkalinc-phosphatase- conjugated 
second antibodies and the alka line phosphatase substrate kit IV BC IP/ NUT 
were used. 
RESU LTS 
To cha racterize furth e r the anti gen m o lecul es in th e presen t case , 
we pel-formcd immuno blot an alysis u s ing n o rmal human epidc rm al 
extracts and bovin e d esm osom e pre p a ratio n s. W ith immun o bl o t-
ti n g of epidermal extracts (Fig 1 , lift), a ll of the six contro l PV sera 
reacted exclu sively w i th th e 130-kO hum an PV A, w h e reas tw o of 
the six PF sera reacted w ith th e 160-kO human P FA. T h e serum of 
the presen t case reacted stron g ly w i th b oth an tigen s. Furth e rmo re, 
it a lso rcacted weakly b ut clearly w ith a d o ublet of IIO-kO and 
t Yue KJ(M, Holton JL, C larke JP, H ya m J LM. H as himo to T, C hidgey 
MAJ, Garrod DR: C haracterisation of a desmocoll.in isoform (bovine Dsc3) 
exclusively exprcssed in lower layers of stratified epi the li a (submi tted fo r 
publication). 
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F igure 1. The patient's serum reacted with all the PFA, PVA, and 
desmocollins with imlt1unoblottillg of dispase-separated epide rlt1al 
extracts (left; E ) and of partially purified bovine desmosome (';gl,t; 
DM). A I1·o lll/teads indicate, from top to bo ttom , PFA , PYA, and the larger 
fo rm " a" and the smallcr fo rm " b " o f desmocollin. R esults show the 
reactivi ty of anti-desmogle in monoclonal an tibody 32-2B (lm,e 1; DG), 
anti-desmocollin m onoclonal antibody 52-3D (/ nlle 2; D C ). tlus patien t's 
serum (/all e 3; Pt) , a contro l PV serum (/alle 4) , and a con tro l PF serum (/all e 
5) . 
IOO- kO pro te ins, whic h sh o w e d th e same mig ra t io n as those 
recognized by the anti- d e smocollin monocl o nal antibody 52-3D. 
N o n e o f othe r sera reacted with these pro te ins. 
With immunobl o tting of b o vine d esmosom e pre parations (Fig 
1 , rigllt) , fo ur o f the six con t ro l PF sera reacte d with the 160-kO 
b o vine P FA, whe re as the three PV sera re ac te d with PFA and 
w eakly with the 13 5-kO bov ine PV A , and o n e PV serum re ac te d 
o nly w ith th e PYA . T his p a ti e nt 's serum strong ly reacte d with PFA 
and also with a d o ublet o f l1 5-kO and I05-kO proteins tha t 
showe d th e sa m e mig ration as the 52-3D monocl o nal antibody, 
with slig htly diffe re n t intensities . 
T h e patie nt's serum re ac te d a t almost the same inte nsi ty with 
b o th PV A and P FA in hum an e pide rm al extrac ts and o nl y wi th PFA 
in bovin e d esmosome pre paratio n s, a lth o ug h the patie nt had a 
clinically and histopatho logicaBy typic al case o f PV . The re fo re, to 
e luc ida te th e p oss ible m ech anism fo r bliste r fo rmatio n indu ced b y 
these antibo dies, w e p e rfo rme d immunoblot analysis of fu sio n 
pro te ins of both PYA and PFA (Fig 2) . T h e E C I-2 domain o f 
human PYA was reco g nized b y this patie nt' s serum and b y aU of the 
six PV sera, but n o t b y any P F o r n o rma l se ra . T h e EC3- 5 d o m a in 
of PV A w as recogni zed b y two o f six PV sera but not b y thi s 
pa t ie nt's serum . The i.ntra cellular domain o f PV A w as strong ly 
recognized b y the 32-2B monoclo n a l antibo dy , confirming the 
sp ecific ity of this fu sio n prote in . However , thi s d o main was n o t 
d etecte d b y an y sera use d in this study, including the patie nt's 
se rum . 
In contra st , the EC I -5 domain o f bovlne PFA w as reco g nized by 
two o f the fo ur PF sera re ac tive with PFA in the bovine d e smosom e 
p reparatio n s, but not b y any othe r sera. C onve rsely , the intracel-
lula r d o main ofboviJle PFA was cl early recognize d by the pa t ie nt' s 
serum and b y the three PV control sera re ac tive with PFA in the 
b oviJle d esmosome pre p aratio n s, as w e B as b y one PF serum. 
Furthe rmo re , th e patie nt' s serum labe le d sp ecifically bovi.ne 
D sc2b fu sio n prote in 111 a m anner simila r to that of t h e 52-3D 
m o noclo nal antibody (Fig 3) . The patient's serum reac te d with 
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Figure 2. The patient's serum reacted with the Eel-2 domain of 
PVA and the intracellular domain of PFA with immunoblotting of 
PVA and PFA fusion proteins. Llji (DG1) shows the results of the 
Eel-5 domain (Ee ) and the intracellular domain (I e ) of bovine PFA: rigll t 
(PY A) shows the results of the Eel-2 domain, the Ee3-5 domain, and the 
intracellular domain (I e) ofhull1an PYA . R esults show the reactivity of this 
patient's serum (Inll e Pt), a control PY serum (lnll e P II), a control PF serum 
(Inll e P1-,,), and anti-dcsmoglein monoclonal antibody 32-28 (In lie DC). Lnlle 
CAL in PYA shows the reactivity of anti-J3-galactosidasc polyclonal 
antibodies. Arrowhends indicate the positions of the fusion protein. 
n e ither Dsc l b nor Dsc3 b. A ll of the results of the immunoblot 
stuclies a re summarized in Table I. 
DISCUSSION 
This case is interesting for at leas t two reasons. First, the serum of 
this patient recognized both PV A and PFA simu ltaneously with 
immul1oblotting of normal human epidermal extracts. Second, this 
patient showed antibodies reactive with human desmocollin. 
Because a considerable number of PY sera immunoprecipi tate 
PFA from radiolabeled human epiderma l extracts (7,8], it is rea-
sonable to assume that some PV sera shou ld also rea c t with both 
PV A and PFA upon immunoblotting of human epiderma l extra cts . 
We cou ld find su ch a concomitant reactivity by some PY sera in 
bovine desmosome preparations, but not in human epidermal 
extracts [9] . We have no exp lanatio n for this discrepancy. It may be 
due to the mu ch lower abundan ce of PFA in epidermal extracts 
than in d esmosome-enriched fractions Or to th e species difFeren ce 
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Figure 3. The patient's serunl reacted with Dsc2b with imnluno-
blotting of bovine desmocollin fusion proteins. Closed rire/es, top to 
bOttOIlI . indicate the positions of molecular weight markers: 200 kD. 116 kD. 
and 97 kD. respectively. Lnlles 1, 2 arc blots ofDsc1b: Inll e" 3,4 arc blots of 
Dsc2b: and IUll es 5, 6 are blots ofDsc3b. An'oll/hends indicate the positions of 
the fusio n proteins. all of which were labe led by 52-3D monoclonal 
antibody (In/l es 1, 3, 5). Lmtes 2, 4, 6 are blots for tlus patient's serum . 
between the two antigen sources. However , this patient's serum 
cleady showed con current reactivity with human PYA and PFA. 
PV cases w ith con comitant anti-PYA and anti-PFA antibodies , 
including the present case, show no features characte ristic of PF. 
T here may b e at least two plausible e,,'Vlanations for this. One 
possibility is that the e fFect of the anti-PYA antibodies predominates 
over the efFect of the anti-PFA antibodies . In other words, because 
PY A is expressed predominantly in the lower epidermis and PFA in 
the higher regions, the PYA-media ted adhesions will be d isrupte d 
before keratinocytes pass to the upper layers, thereby masking an y 
additional PFA dysfun ction . Another possibili ty is that th e allti-PY A 
antibodies have p athogenic ac tivity but the anti-PFA antibodies in 
these PV sera a re nonpathogenic. The ,-esults of iml11unoblotting of 
PYA and PFA fusion proteins in this study suggest the latter. T h e 
anti-PFA and anti-PYA antibodies in the present case have difFerent 
types of targets, i.e., th e serum reacted with the extracellular 
domain of PYA and with the intracellul ar domain of PFA. There-
fore, it is con ceivable that the production of antibodies against the 
intracellular domain of PFA in PV ma y b e an epiphenom en on 
induced after the cell m embrane is d am aged by pathogenic allti-
bodies against th e extracellular dom ains of PYA. Although the 
intracellula r domain of PVA was not detected by an y sera u sed in 
this study, furth e r study of more patients' sera will be needed to 
Table I. Sumtnary of Iannlunoblotting Data for the Sera and Monoclonal Antibodies Used in This Study" 
Fusion Pro teins 
Human Epidermal Bovine Desmosome 
Extracts Preparations PFA PYA Dsc 
PFA PYA Dsc PFA PYA Dsc EC1-5 IC EC1-2 EC3-5 IC Dscl Dsc2 Dsc3 
Present case + + + + + + + + 
32-213 + + + + + + ND ND NO 
52-3 D + + ND ND ND + + + 
PV sera (n = 6) 0 6 0 3 4 0 0 3 G 2 0 ND ND ND 
PF sera (n = G) 2 0 0 4 0 0 2 I 0 0 0 ND NI ND 
Normal (n = 6) 0 0 0 0 0 0 0 0 () 0 0 ND ND ND 
"Dat:1 arc prese llted as +. positive fo r Ihe pro fcil1 : - . Il cg;lI'ivc fo r the protei n ; or ilS the l1ulI1be r o f sera rC;l c tivc with the prol"c ill . Dsc. dcslllocollin: Ie. inlT:l ccliul ar dom :l.in: 
ND. 1I0t done. 
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obtain a final conclusion. Nevertheless, this study showed that the 
ECl-2 domain is recognized specifi cally by PV sera but not by any 
PF sera, confi rming the results of the previous study [15] and 
suggesting that tllis reactivity may be a specific marker for PV sera. 
Upon repea ted immunoblot studies of human epidermal extracts, 
tllis patient' s serum showed a weak bu t clear reactivity with doublet 
protein bands of 110 kD and 100 kD , which is the same reactiv ity 
as that of aJlti-desmocollin monoclonal antibody. Furthermore, the 
patient's serum reacted specifica lly with bovine Dsc2b fusion 
protein. It is not known w hy only th e present case can detect 
human desmoco llin , w hereas a considerable number of pemphjgus 
sera react specifically with desmocoBin in bovine desmosome 
preparations [4,12]. T his may be beca use the amount of desmocol-
lin in human epidermal extracts is too low to be detected by 
pemprugus sera. Another possible explanati on is the species differ-
ence between the antigen sources. . 
It is interesting tha t the patient's serum recognized only Dsc2b, 
and not Dsc1b or Dsc3 b. O ne possible reason is that tlus serum 
reacted with Dsc2b-specific epitopes . T his speculation sho uld be 
proved or disproved by future epitope-mappill g studies. 
T llis study helps clarifY the nature of anti-desl11osomaJ cadherin 
autoantibodies in pemplligus. T he issue of antigen recogllition in 
various types of pemphigus seems to be mu ch more complica ted 
than assumed previously. However, future studies to elucidate 
many questions in tllis field should g ive us further insight into 
keratinocyte ceU biology and cellular and hum oral immunology in 
pemphigus. 
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